文献速递腹部技术与安全MR

基于多参数MRI的影像组学分析预测胃癌淋巴结转移与生存结局:一项双中心研究

Multiparametric MRI-based Radiomics Analysis for Prediction of Lymph Node Metastasis and Survival Outcome in Gastric Cancer: A Dual-center Study.
PubMed 文献 · Acad Radiol · 2024-06-08

双中心回顾性纳入479例胃癌患者,术前多参数MRI提取1595个影像特征构建单序列及多序列影像组学模型;多序列模型预测淋巴结转移的AUC在训练集为0.774、两个验证集分别为0.721和0.720,优于单序列模型,且与无病生存和总生存显著相关(均P<0.05)。

要点

  • 多序列MRI影像组学模型预测胃癌淋巴结转移的AUC在训练集为0.774、验证集为0.721和0.720。
  • 基于对比增强T1加权成像的单序列模型表现优于其他两个单序列模型。
  • 多序列模型与胃癌患者无病生存和总生存均显著相关(均P<0.05)。

核心结论

  • 基于原发灶的多参数MRI影像组学模型在预测胃癌淋巴结转移和生存结局方面表现出中等性能,可能为个体化治疗策略提供有价值的信息。

研究设计与样本

  • 双中心回顾性研究,纳入479例根治性胃切除术前接受多参数MRI的胃癌患者,从T2加权成像、表观扩散系数图和对比增强T1加权成像分别提取1595个影像特征,采用Boruta和模拟退火算法筛选特征并构建单序列及多序列影像组学模型。

诊断标准与关键数值

  • 多序列影像组学模型预测淋巴结转移的AUC在训练集为0.774(95%CI 0.703-0.845)、验证集1为0.721(95%CI 0.593-0.850)、验证集2为0.720(95%CI 0.639-0.801),优于单序列模型;基于对比增强T1加权成像的模型优于其他两个单序列模型;多序列模型与无病生存和总生存均显著相关(均P<0.05)。

临床应用与阅片要点

  • 作者认为,基于原发灶的多参数MRI影像组学模型在预测胃癌淋巴结转移和生存结局方面表现出中等性能,可能为个体化治疗策略提供有价值的信息。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: Gastric cancer (GC) is highly heterogeneous, and accurate preoperative assessment of lymph node status remains challenging. We aimed to develop a multiparametric MRI-based model for predicting lymph node metastasis (LNM) in GC and to explore its prognostic implications.

MATERIALS AND METHODS: In this dual-center retrospective study, 479 GC patients undergoing preoperative multiparametric MRI before radical gastrectomy were enrolled. 1595 imaging features were extracted from T2-weighted imaging, apparent diffusion coefficient maps, and contrast-enhanced T1-weighted imaging (cT1WI), respectively. Feature selection steps, including the Boruta and Simulated Annealing algorithms, were conducted to identify key features. Different radiomics models (RMs) based on the single- and multiple-sequence were constructed. The performance of various RMs in predicting LNM was assessed in terms of discrimination, calibration, and clinical usefulness. Additionally, Kaplan-Meier survival curves were employed to estimate differences in disease-free survival (DFS) and overall survival (OS).

RESULTS: The multi-sequence radiomics model (MRM) achieved area under the curves (AUCs) of 0.774 [95 % confidence interval (CI), 0.703-0.845], 0.721 (95 % CI, 0.593-0.850), and 0.720 (95 % CI, 0.639-0.801) in the training and two validation cohorts, respectively, outperforming the single-sequence RMs. Notably, the RM derived from cT1WI demonstrated superior performance compared to the other two single-sequence models. Furthermore, the proposed MRM exhibited a significant association with DFS and OS in GC patients (both P < 0.05).

CONCLUSION: The multiparametric MRI-based radiomics model, derived from primary lesions, demonstrated moderate performance in predicting LNM and survival outcomes in patients with GC, which could provide valuable insights for personalized treatment strategies.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Song R, Chen W, Zhang J, et al. Multiparametric MRI-based Radiomics Analysis for Prediction of Lymph Node Metastasis and Survival Outcome in Gastric Cancer: A Dual-center Study. Acad Radiol. 2024. PMID: 38849259. doi:10.1016/j.acra.2024.05.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。